1887

Abstract

Worldwide, about one-tenth of end-stage renal disease (ESRD) patients are on peritoneal dialysis (PD). Peritonitis is a major cause of PD failure and change of therapy to haemodialysis. An update on peritoneal dialysis-related infections has recommended the use of a first generation cephalosporin or vancomycin as an empirical therapy for Gram-positive organisms. spp. is a Gram-positive environmental cocci that have been increasingly reported from various nosocomial infections but very rarely from peritoneal dialysis infections. It is intrinsically resistant to Vancomycin but sensitive to ampicillin. So, diagnosis of this bacteria is important if isolated from PD infections.

An elderly female patient of ESRD on continuous ambulatory peritoneal dialysis (CAPD) was admitted with complaints of high fever and cloudy PD effluent for 2 days. She was started with vancomycin and imipenem empirically but did not improve even after 4 days. Pus cells were seen when PD fluid was examined microscopically. BACTEC culture of PD fluid isolated growth of Gram-positive cocci, which was confirmed as . It was resistant to vancomycin. The antibiotic of the patient was changed to ciprofloxacin IV. The patient responded in 2 days and was discharged after 7 days.

This is the first case report of peritonitis in an ESRD patient on CAPD. Accurate diagnosis and antibiotic sensitivity test of the bacteria is important especially if isolated in critical patients as it is intrinsically resistant to vancomycin.

Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000007
2019-07-01
2019-08-23
Loading full text...

Full text loading...

/deliver/fulltext/acmi/1/5/acmi000007.html?itemId=/content/journal/acmi/10.1099/acmi.0.000007&mimeType=html&fmt=ahah

References

  1. Prasad KN, Singh K, Rizwan A, Mishra P, Tiwari D et al. Microbiology and outcomes of peritonitis in northern India. Perit Dial Int 2014;34:188–194 [CrossRef]
    [Google Scholar]
  2. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011;31:651–662 [CrossRef]
    [Google Scholar]
  3. Brown MC, Simpson K, Kerssens JJ, Mactier RA. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000–2007). Perit Dial Int 2011;31:639–650 [CrossRef]
    [Google Scholar]
  4. Hsieh YP, Chang CC, Wang SC, Wen YK, Chiu PF et al. Predictors for and impact of high peritonitis rate in Taiwanese continuous ambulatory peritoneal dialysis patients. Int Urol Nephrol 2015;47:183–189 [CrossRef]
    [Google Scholar]
  5. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006;70:S55–S62 [CrossRef]
    [Google Scholar]
  6. Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992;42:967–974 [CrossRef]
    [Google Scholar]
  7. Schleifer CR, Benz RL, McAlack R, Poupard J, Calmon J. Lactobacillus acidophilus peritonitis in CAPD. Perit Dial Int 1989;9:222–223
    [Google Scholar]
  8. Gillespie RS, Symons JM, McDonald RA. Peritonitis due to Leuconostoc species in a child receiving peritoneal dialysis. Pediatr Nephrol 2002;17:966–968 [CrossRef]
    [Google Scholar]
  9. Hoque S, Weir A, Fluck R, Cunningham J. Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. Nephrol Dial Transplant 1996;11:2340–2341 [CrossRef]
    [Google Scholar]
  10. Badrising S, Bakker L, Lobatto S, van Es A. Peritonitis in a peritoneal dialysis patient due to Rhizobium radiobacter and Moraxella osleonsis: case report and literature review. Perit Dial Int 2014;34:813–815 [CrossRef]
    [Google Scholar]
  11. Misra R, Prasad KN, Singh K, Bhadauria D, Sharma RK. Rhizobium radiobacter peritonitis: the first case report from India and review. JMM Case Rep 2014;1:e004051 [CrossRef]
    [Google Scholar]
  12. Kocyigit I, Öztürk F, Kargi S, Uzun I, Unal A et al. Peritoneal dialysis-related peritonitis due to Kingella denitrificans: the first case report. Perit Dial Int 2014;34:819–820 [CrossRef]
    [Google Scholar]
  13. Mastro TD, Spika JS, Lozano P, Appel J, Facklam RR. Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis 1990;161:956–960 [CrossRef]
    [Google Scholar]
  14. Suh B. Resolution of persistent Pediococcus bacteremia with daptomycin treatment: case report and review of the literature. Diagn Microbiol Infect Dis 2010;66:111–115 [CrossRef]
    [Google Scholar]
  15. Bernabeu JL, Leo E, Trigo C, Herrera JM, Sousa JM et al. Crohn's disease and liver abscess due to Pediococcus sp. Inflamm Bowel Dis 2011;17:2207–2208 [CrossRef]
    [Google Scholar]
  16. Barros RR, Carvalho MG, Peralta JM, Facklam RR, Teixeira LM. Phenotypic and genotypic characterization of Pediococcus strains isolated from human clinical sources. J Clin Microbiol 2001;39:1241–1246 [CrossRef]
    [Google Scholar]
  17. Riebel WJ, Washington JA. Clinical and microbiologic characteristics of pediococci. J Clin Microbiol 1990;28:1348–1355
    [Google Scholar]
  18. Colman G, Efstratiou A. Vancomycin-resistant leuconostocs, lactobacilli and now pediococci. J Hosp Infect 1987;10:1–3 [CrossRef]
    [Google Scholar]
  19. Ruoff KL, Kuritzkes DR, Wolfson JS, Ferraro MJ. Vancyomycin-resistant gram-positive bacteria isolated from human sources. J Clin Microbiol 1988;26:2064–2068
    [Google Scholar]
  20. Nelson RRS. Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control. J Hosp Infect 1999;42:275–282 [CrossRef]
    [Google Scholar]
  21. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990;34:543–549 [CrossRef]
    [Google Scholar]
  22. Sims W. The isolation of pediococci from human saliva. Arch Oral Biol 1966;11:967–972 [CrossRef]
    [Google Scholar]
  23. Seale DR. Bacterial inoculants as silage additives. J Appl Bacteriol 1986;61:9–26
    [Google Scholar]
  24. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996;7:2176–2182
    [Google Scholar]
  25. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002;22:573–581
    [Google Scholar]
  26. Stinghen AE, Barretti P, Pecoits-Filho R. Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int 2007;27:S281–285
    [Google Scholar]
  27. Voss A. Miscellaneous organisms. Infect Dis Ther 1997;20:157–182
    [Google Scholar]
  28. Facklam R, Elliott JA. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev 1995;8:479–495 [CrossRef]
    [Google Scholar]
  29. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393–423 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000007
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error